A new trading day began on Tuesday, with Axsome Therapeutics Inc (NASDAQ: AXSM) stock price up 4.62% from the previous day of trading, before settling in for the closing price of $91.93. AXSM’s price has ranged from $64.11 to $105.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 110.20% over the last five years. Meanwhile, its annual earnings per share averaged -3.08%. With a float of $39.60 million, this company’s outstanding shares have now reached $48.44 million.
The firm has a total of 545 workers. Let’s measure their productivity. In terms of profitability, gross margin is 90.55%, operating margin of -90.84%, and the pretax margin is -91.97%.
Axsome Therapeutics Inc (AXSM) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Axsome Therapeutics Inc is 18.28%, while institutional ownership is 79.22%. The most recent insider transaction that took place on Sep 11 ’24, was worth 1,005,871. In this transaction Director of this company sold 11,016 shares at a rate of $91.31, taking the stock ownership to the 10,002 shares. Before that another transaction happened on Sep 11 ’24, when Company’s Director proposed sale 11,016 for $91.31, making the entire transaction worth $1,005,843.
Axsome Therapeutics Inc (AXSM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.98 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.08% per share during the next fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Here are Axsome Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.54, a number that is poised to hit -0.96 in the next quarter and is forecasted to reach -1.62 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Analysing the last 5-days average volume posted by the [Axsome Therapeutics Inc, AXSM], we can find that recorded value of 0.99 million was lower than the volume posted last year of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 81.89%. Additionally, its Average True Range was 4.74.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 70.04%, which indicates a significant decrease from 89.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.59% in the past 14 days, which was higher than the 44.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $92.56, while its 200-day Moving Average is $84.83. Now, the first resistance to watch is $99.14. This is followed by the second major resistance level at $102.09. The third major resistance level sits at $105.69. If the price goes on to break the first support level at $92.59, it is likely to go to the next support level at $88.99. Now, if the price goes above the second support level, the third support stands at $86.04.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
With a market capitalization of 4.66 billion, the company has a total of 48,462K Shares Outstanding. Currently, annual sales are 270,600 K while annual income is -239,240 K. The company’s previous quarter sales were 104,760 K while its latest quarter income was -64,600 K.
